Earlier this fall, PCORI (the Patient Centered Outcomes Research Institute) released a request for funding applications for comparative effectiveness studies of Multiple sclerosis (MS) disease modifying therapies (DMTs). This includes…
Read More
We have an update for you regarding Ocrelizumab – the investigational disease modifying therapy that we have told you about over the past several months. Last week, the FDA…
Get Ready for Ski Season with Adaptive Ski Passes! The snow has started falling in the mountains and ski season is beginning here in the Rockies! If you are a…
Diane Kuehnast is swimming the English Channel many times over. But she avoids the cold, treacherous waters. Twice per week, Diane swims in the pools at the Englewood Recreation…
Dear Patients: It is with mixed emotions that I am announcing I am leaving the University of Colorado. It has been my great pleasure being part of your care over…
UCHealth rolls out its first outpatient telehealth service First there was telestroke, which starting in July 2014 connected fellowship-trained neurologists based at UCHealth Metro Denver with emergency department physicians at…
At the Rocky Mountain MS Center, we are always seeking to develop a deeper understanding of patient viewpoints and we would like to hear from you about your experience, so…
Dr. Timothy Vollmer (left) with Dr. Donald H. Gilden. Dr. Donald H. Gilden, former Chairman of the Department of Neurology, University of Colorado Denver School of Medicine, passed away on…
One of the most difficult decisions for someone who’s been living with MS for a long time is whether or not to discontinue their treatment with disease modifying therapies (DMTs)….
In this issue of eMS news, we hear from Ian Shelton. Ian is the recipient of our inaugural Rocky Mountain MS Center Undergraduate Research Experience Scholarship. He is working…